Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Abatacept> ?p ?o. }
Showing items 1 to 70 of
70
with 100 items per page.
- Abatacept abstract "Abatacept (marketed as Orencia) is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. It is a molecule capable of binding with more avidity to CD80 (B7-1) than to CD86 (B7-2). Abatacept is a selective co-stimulation modulator as it inhibits the costimulation of T cells. It was developed by Bristol-Myers Squibb and is licensed in the United States for the treatment of rheumatoid arthritis in the case of inadequate response to anti-TNFα therapy.".
- Abatacept atcPrefix "L04".
- Abatacept atcSuffix "AA24".
- Abatacept casNumber "213252-14-3".
- Abatacept drugbank "DB01281".
- Abatacept fdaUniiCode "7D0YB67S97".
- Abatacept wikiPageExternalLink en&t=634475600483187694.
- Abatacept wikiPageExternalLink index.jsp?BV_UseBVCookie=Yes.
- Abatacept wikiPageID "9514706".
- Abatacept wikiPageRevisionID "604761912".
- Abatacept atcPrefix "L04".
- Abatacept atcSuffix "AA24".
- Abatacept casNumber "213252".
- Abatacept chembl "1201823".
- Abatacept chemspiderid "NA".
- Abatacept drugbank "DB01281".
- Abatacept eliminationHalfLife "1131840.0".
- Abatacept hasPhotoCollection Abatacept.
- Abatacept kegg "D03203".
- Abatacept legalStatus "POM , ℞-only".
- Abatacept medlineplus "a606016".
- Abatacept pregnancyCategory "C".
- Abatacept routesOfAdministration Intravenous_therapy.
- Abatacept tradename "Orencia".
- Abatacept unii "7".
- Abatacept verifiedfields "changed".
- Abatacept verifiedrevid "477237032".
- Abatacept subject Category:Bristol-Myers_Squibb.
- Abatacept subject Category:Engineered_proteins.
- Abatacept subject Category:Immunosuppressants.
- Abatacept type Abstraction100002137.
- Abatacept type Chemical114806838.
- Abatacept type Compound114818238.
- Abatacept type EngineeredProteins.
- Abatacept type Macromolecule114944888.
- Abatacept type Material114580897.
- Abatacept type Matter100020827.
- Abatacept type Molecule114682133.
- Abatacept type OrganicCompound114727670.
- Abatacept type Part113809207.
- Abatacept type PhysicalEntity100001930.
- Abatacept type Protein114728724.
- Abatacept type Relation100031921.
- Abatacept type Substance100019613.
- Abatacept type Thing100002452.
- Abatacept type Unit109465459.
- Abatacept type Drug.
- Abatacept type DrugProduct.
- Abatacept type FunctionalSubstance.
- Abatacept comment "Abatacept (marketed as Orencia) is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. It is a molecule capable of binding with more avidity to CD80 (B7-1) than to CD86 (B7-2). Abatacept is a selective co-stimulation modulator as it inhibits the costimulation of T cells.".
- Abatacept label "Abatacept".
- Abatacept label "Abatacept".
- Abatacept label "Abatacept".
- Abatacept label "Abatacept".
- Abatacept label "Abatacept".
- Abatacept label "Abatacept".
- Abatacept sameAs Abatacept.
- Abatacept sameAs Abatacept.
- Abatacept sameAs Abatacept.
- Abatacept sameAs Abatacept.
- Abatacept sameAs Abatacept.
- Abatacept sameAs m.02phdqs.
- Abatacept sameAs Q2697833.
- Abatacept sameAs Q2697833.
- Abatacept sameAs abatacept.
- Abatacept sameAs DB01281.
- Abatacept sameAs Abatacept.
- Abatacept wasDerivedFrom Abatacept?oldid=604761912.
- Abatacept homepage index.jsp?BV_UseBVCookie=Yes.
- Abatacept isPrimaryTopicOf Abatacept.